Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2020
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic CancerJacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2024
NRG Oncology International Consensus Contouring Atlas on Target Volumes and Dosing Strategies for Dose-Escalated Pancreatic Cancer Radiation TherapyNina N Sanford, Amol K Narang, Todd A Aguilera, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2019
The transformation of radiation oncology using real-time magnetic resonance guidance: A reviewWilliam A Hall, Eric S Paulson, Uulke A van der Heide, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2026
Tumor matrix proteoglycan accumulation and processing alters T cell effector function and the response to immunotherapy in patients with oligometastatic colorectal cancerDustin A Deming, Sean G Kraus, Joshua Brand, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2023
Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 studyMichael D Chuong, Percy Lee, Daniel A Low, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2023
A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic CancerParag Jitendra Parikh, Percy Lee, Daniel A Low, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and RadiationCheri A Pasch, Peter F Favreau, Alexander E Yueh, et al.
Scientific Reports|April 8, 2025
Subclonal response heterogeneity to define cancer organoid therapeutic sensitivityJeremy D Kratz, Shujah Rehman, Katherine A Johnson, et al.
Pageof 6